Medicare Enrolled

Dr. Olujimi Adefisan, M.D

Child & Adolescent Psychiatry Physician · Atlanta, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
2150 PEACHFORD RD STE A, Atlanta, GA 30338
7706740553
In practice since 2008 (18 years)
NPI: 1790947216 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Adefisan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Adefisan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Adefisan

Dr. Olujimi Adefisan is a child & adolescent psychiatry physician in Atlanta, GA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Adefisan performed 49 Medicare services across 20 unique beneficiaries.

Between the years covered by Open Payments, Dr. Adefisan received a total of $12,250 from 33 pharmaceutical and/or device companies across 699 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in child & adolescent psychiatry physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Adefisan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ 49 Medicare services $12,250 industry payments

Medicare Practice Summary

Medicare Utilization ↗
49
Medicare services
Bottom 8% in GA for child & adolescent psychiatry physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
20
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Electrical stimulation therapy
A treatment that uses electrical currents to stimulate nerves or muscles. The specific purpose of the therapy is not defined in the code description.
 49 $82 $269
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,250
Total received (2018-2024)
Avg $1,750/year across 7 years
Top 7% in GA for child & adolescent psychiatry physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
699
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,250 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,390
2023
$2,542
2022
$2,337
2021
$1,705
2020
$429
2019
$1,691
2018
$1,156

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$378
Teva Pharmaceuticals USA, Inc.
$364
Neurocrine Biosciences, Inc.
$256
Janssen Pharmaceuticals, Inc
$227
Alkermes, Inc.
$215
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$172
Takeda Pharmaceuticals U.S.A., Inc.
$162
Lundbeck LLC
$145
Corium, LLC
$79
Otsuka America Pharmaceutical, Inc.
$76
E.R. Squibb & Sons, L.L.C.
$59
Supernus Pharmaceuticals, Inc.
$48
Axsome Therapeutics, Inc.
$43
Tris Pharma Inc
$38
Noven Therapeutics, LLC
$37
Almatica Pharma LLC
$25
Neos Therapeutics, LP
$23
Indivior Inc.
$22
IDORSIA PHARMACEUTICALS US INC
$22
Top 3 companies account for 41.7% of 2024 payments
All-time payments by company (2018-2024) ›
Alkermes, Inc.
$1,588
Janssen Pharmaceuticals, Inc
$1,585
Lundbeck LLC
$1,166
Neurocrine Biosciences, Inc.
$950
Otsuka America Pharmaceutical, Inc.
$922
Takeda Pharmaceuticals U.S.A., Inc.
$855
Teva Pharmaceuticals USA, Inc.
$810
ITI, Inc.
$679
Sunovion Pharmaceuticals Inc.
$597
ABBVIE INC.
$572
AbbVie Inc.
$520
Vanda Pharmaceuticals Inc.
$422
Corium, LLC
$366
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$172
Allergan Inc.
$155
Indivior Inc.
$121
Noven Therapeutics, LLC
$113
Shire North American Group Inc
$96
Supernus Pharmaceuticals, Inc.
$89
Axsome Therapeutics, Inc.
$69
E.R. Squibb & Sons, L.L.C.
$59
IDORSIA PHARMACEUTICALS US INC
$58
Neos Therapeutics, LP
$48
Tris Pharma Inc
$38
Ironshore Pharmaceuticals Inc.
$36
Allergan, Inc.
$30
Biogen, Inc.
$28
Almatica Pharma LLC
$25
BioXcel Therapeutics, Inc.
$24
Corium, Inc.
$18
OWP Pharmaceuticals, Inc.
$16
ARBOR PHARMACEUTICALS, INC.
$13
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 35.4% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aristada 441 mg · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · COBENFY · Dyanavel XR · Evekeo · FANAPT · HETLIOZ · Hetlioz · IGALMI · INGREZZA · INVEGA SUSTENNA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LONHALA MAGNAIR · LOREEV XR · MYDAYIS · PERSERIS · QELBREE · QUVIVIQ · Qelbree · REXULTI · SECUADO · SPRAVATO · SUBLOCADE · Secuado · Subvenite · TRINTELLIX · Trintellix · UZEDY · VIVITROL · VRAYLAR · VYVANSE · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for child & adolescent psychiatry physician in GA.

Looking for a child & adolescent psychiatry physician in Atlanta?
Compare child & adolescent psychiatry physicians in the Atlanta area by procedure volume, costs, and industry payment transparency.
Browse child & adolescent psychiatry physicians nearby

Geographic Context

Child & adolescent psychiatry physicians within 10 mi
85
Per 100K population
11.2
County median income
$77,683
Nearest hospital
PEACHFORD BEHAVIORAL HEALTH SYSTEM OF ATLANTA
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Adefisan is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 7% of GA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Adefisan experienced with electrical stimulation therapy?
Based on Medicare claims data, Dr. Adefisan performed 49 electrical stimulation therapy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Adefisan receive payments from pharmaceutical companies?
Yes. Dr. Adefisan received a total of $12,250 from 33 companies across 699 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Adefisan's costs compare to other child & adolescent psychiatry physicians in Atlanta?
Dr. Adefisan's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Adefisan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Child & Adolescent Psychiatry Physicians in Atlanta
Browse child & adolescent psychiatry physicians in Atlanta ranked by procedure volume and transparency data.
Highest volume
Top Child & Adolescent Psychiatry Physicians in GA
Child & adolescent psychiatry physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Child & Adolescent Psychiatry Physicians in GA
Which GA child & adolescent psychiatry physicians receive the most from drug and device companies.
By company
Alkermes, Inc. Payments to Doctors
See all physicians who received payments from Alkermes, Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Lundbeck LLC Payments to Doctors
See all physicians who received payments from Lundbeck LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →